Y-27632 dihydrochloride

Y-27632 dihydrochloride

Contact us: [email protected]

Y-27632 dihydrochloride

GK8578-1MG 1 mg
EUR 170.4

Y-27632 dihydrochloride

GK8578-25MG 25 mg
EUR 945.6

Y-27632 dihydrochloride

GK8578-5MG 5 mg
EUR 399.6

Y-27632 (dihydrochloride)

HY-10583 50mg
EUR 349.2

Y-27632, dihydrochloride

1596-1 each
EUR 210

Y-27632, dihydrochloride

1596-5 each
EUR 555.6

Y-27632, dihydrochloride

1596-50 each
EUR 2962.8

Y-27632

E1KS1049 2 mg
EUR 390

Y 27632

20-abx076548
  • EUR 326.40
  • EUR 627.60
  • 1 mg
  • 5 mg

Y-27632

B1293-10 10 mg
EUR 170.4
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-200 200 mg
EUR 1284
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-5.1 10 mM (in 1mL DMSO)
EUR 129.6
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

B1293-50 50 mg
EUR 505.2
Description: Y-27632 is a specific inhibitor of Rho-associated kinases(ROCK) family with Ki values of 0.22?M and 0.30?M for ROCK1 and ROCK2, respectively.Y-27632 has shown selectivity of inhibition by comparing their Ki values for other Rho effector kinases, citron kinase and PKN, as well as PKC?.

Y-27632

HY-10071 100mg
EUR 1480.8

EZSolution? Y-27632

1784-5 each
EUR 535.2

Y 27632 (ROCK kinase inhibitor)

SIH-486-1MG 1 mg
EUR 178.8
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y 27632 (ROCK kinase inhibitor)

SIH-486-5MG 5 mg
EUR 393.6
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

EZSolution? Y-27632, Sterile-Filtered

1994-1 each
EUR 430.8

Y-39983 dihydrochloride

B1176-10 10 mg
EUR 494.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride

B1176-100 100 mg
EUR 2881.2
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-39983 dihydrochloride

B1176-50 50 mg
EUR 1796.4
Description: Y-39983 dihydrochloride is a novel and selective inhibitor of ROCK family with IC50 value of 3.6nM for ROCK [1].

Y-33075 (dihydrochloride)

HY-10069 5mg
EUR 258

SNRPF Polyclonal Antibody

27632-100ul 100ul
EUR 302.4

SNRPF Polyclonal Antibody

27632-50ul 50ul
EUR 224.4

JNJ-26481585

27632-1 5 mg
EUR 235
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation.

JNJ-26481585

27632-2 10 mg
EUR 305
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation.

JNJ-26481585

27632-3 50 mg
EUR 495
Description: JNJ-26481585, also known as Quisinostat, is a potent pan-HDAC inhibitor. JNJ-26481585 induces histone acetylationand inhibits cancer cell proliferation.

Cefotiam Dihydrochloride

C095-100MG 100 mg
EUR 278.4

Cefotiam Dihydrochloride

C095-50MG 50 mg
EUR 172.8

Chlorhexidine Dihydrochloride

C157-25G 25 g
EUR 222

Chlorhexidine Dihydrochloride

C157-5G 5 g
EUR 86.4

Retigabine dihydrochloride

A3758-10 10 mg
EUR 164.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-100 100 mg
EUR 522
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5 5 mg
EUR 126
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-5.1 10 mM (in 1mL DMSO)
EUR 170.4
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Retigabine dihydrochloride

A3758-50 50 mg
EUR 325.2
Description: IC50: N/ARetigabine is a first-in-class K+ channel (KCNQ) opener.

Veliparib dihydrochloride

A3958-10 10 mg
EUR 177.6
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-200 200 mg
EUR 1002
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5 5 mg
EUR 150
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-5.1 10 mM (in 1mL DMSO)
EUR 139.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Veliparib dihydrochloride

A3958-50 50 mg
EUR 421.2
Description: Veliparib dihydrochloride is a potent inhibitor of PARP-1 and PARP-2 with K (i) s of 5.2 and 2.9 nmol/L, respectively [1].PARP is short of poly ADP ribose polymerase and is reported as an overexpressed enzyme in a variety of cancers.

Y-27632 dihydrochloride